A randomized, controlled trial comparing the immunogenicity of 2 doses vs 3 doses of the 9-valent HPV vaccine in males and females 15- 26 years of age

Project: Research project

Project Details

StatusActive
Effective start/end date3/1/192/28/25

Funding

  • Cancer Prevention and Research Institute: $1,491,473.00